Healthcare >> CEO Interviews >> September 14, 2001
HARRY M. JANSEN KRAEMER, JR., became CEO of Baxter International, Inc.,
in January 1999, and assumed the additional responsibility of Chairman
of Baxter's Board of Directors in January 2000. Mr. Kraemer joined
Baxter in 1982 as Director of Corporate Development. His career at
Baxter has included senior positions in both domestic and international
operations. In 1993, he was named Senior Vice President and CFO,
responsible for all financial operations, business development,
communications, and European operations. Over the next several years, he
assumed additional responsibility for the company's Renal, Medication
Delivery, Japan, and Fenwal businesses. In April 1997, Mr. Kraemer was
named President of Baxter International Inc. Before joining Baxter, Mr.
Kraemer worked for Bank of America in corporate banking, and for
Northwest Industries in planning and business development. Active in
business, education and civic affairs, Mr. Kraemer serves on the Boards
of Directors of Comdisco, Inc., Evanston Northwestern Healthcare,
Science Applications International Corporation, and is on the Dean's
Advisory Board of Northwestern University's J.L. Kellogg Graduate School
of Management. He serves on the Board of Trustees for Lawrence
University and Northwestern University. He is a member of the Business
Roundtable, the Business Council, the Healthcare Leadership Council, the
Chicago Club, and the Commercial Club of Chicago. For his outstanding
leadership and service, he received the 1996 Schaffner Award from
Northwestern University's J.L. Kellogg Graduate School of Management.
Mr. Kraemer graduated Summa cum laude from Lawrence University in
Wisconsin in 1977 with Bachelor's degrees in Mathematics and Economics.
He received a Master's of Management degree in Finance and Accounting
from Northwestern University's J.L. Kellogg Graduate School of
Management in 1979. He is a Certified Public Accountant. Profile
TWST: Could you describe the history and evolution of BaxterInternational?
Mr. Kraemer: Baxter is a global leading healthcare company that's
involved in providing critical therapies to